glp 2tz vs tirzepatide What is the Difference Between GLP-1, GLP-2, and GLP-3? Tirzepatide vs Semaglutide: Key Differences

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications

Im back at the weight I was before I had my daughter and son, and people are putting side-by-side photos of me three months postpartum, she said in response to the Ozempic rumors

(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)

2024 Jan 5;22(1):26

(3) Notably, only 53.8% of those prescribed a GLP-1 agonist in 2022 had a history of type 2 diabetes, highlighting a shifting clinical paradigm in which these agents are now widely used for obesity management and related metabolic disorders

Castrucci AM, Hadley ME, Sawyer TK, Hruby VJ